Subscribe
Logo small
Search

AOTMiT: The Transparency Council will evaluate, among others, the drug for acute promyelocytic leukemia

MedExpress Team

Medexpress

Published Aug. 26, 2022 08:24

AOTMiT: The Transparency Council will evaluate, among others, the drug for acute promyelocytic leukemia - Header image
Źródło: AOTMiT
On Monday, September 5, another meeting of the Transparency Council.

The agenda includes:
Preparation of a position on the legitimacy of granting consent for the reimbursement of the Tript-OH (oxitriptan) medicinal product in the indication: tetrahydrobiopterin deficits....

Content locked

To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].

If you already have an account, please log in

Szukaj nowych pracowników

Dodaj ogłoszenie już za 4 zł dziennie*.

* 4 zł netto dziennie. Minimalny okres ekspozycji ogłoszenia to 30 dni.

Read also